Skip to main content

Table 1 Anthropometric and clinical measurements of study participants at baseline and 12 wk for each treatment group1

From: Dietary fat and not calcium supplementation or dairy product consumption is associated with changes in anthropometrics during a randomized, placebo-controlled energy-restriction trial

  Dairy (n = 22 ) Calcium (n = 16) Placebo (n = 23)
Characteristic Baseline 12 wk Baseline 12 wk Baseline 12 wk
Age (y) 25.1 ± 5.3 25.2 ± 4.9 24.2 ± 4.7
Sex, No.(%)       
Female 18 (82) 14 (88) 18 (78)
Male 4 (18) 2 (13) 5 (22)
Height (cm) 166.9 ± 6.0 164.6 ± 9.0 166.1 ± 7.6
Glucose (mmol/L) 2,3 4.6 ± 0.4 4.6 ± 0.4 4.8 ± 0.4 4.8 ± 0.5 4.8 ± 0.5 4.8 ± 0.4
Insulin (pmol/L) 2 42.5 ± 28.5 33.5 ± 29.0** 41.8 ± 26.2 35.1 ± 21.1** 35.7 ± 14.7 29.9 ± 10.3**
HOMA-IR2,3 1.3 ± 0.9 1.0 ± 0.9** 1.3 ± 0.9 1.1 ± 0.8** 1.1 ± 0.5 0.9 ± 0.3**
Weight (kg)2 79.1 ± 12.1 74.8 ± 10.4** 79.2 ± 12.6 75.8 ± 10.6** 79.7 ± 11.7 76.5 ± 11.2**
BMI2 28. 3 ± 3.0 26.7 ± 2.5** 29.1 ± 2.7 28.1 ± 2.6** 28.8 ± 2.7 27.7 ± 2.8**
LM (%)2 54.5 ± 5.9 57.9 ± 6.6** 58.3 ± 6.6 58.7 ± 7.0** 55.0 ± 5.9 56.9 ± 5.9**
BF (%)2 41.2 ± 5.7 37.7 ± 6.5** 37.6 ± 6.2 36.0 ± 6.7** 40.9 ± 5.2 38.8 ± 5.2**
WC (cm)2,3 88.9 ± 9.6 81.1 ± 8.6** 88.1 ± 9.2 83.3 ± 7.5** 87.4 ± 11.8 82.6 ± 11.3**
  1. 1Data are means ± SD; n = 61 unless otherwise indicated. WC, waist circumference; LM, lean mass. There were no significant differences in baseline anthropometrics or plasma metabolites among treatment groups (ANOVA).
  2. 2Repeated Measures ANOVA to test the effect of time; confirmed with paired sample t-test for significant differences between baseline and 12 wk, *P < 0.01, **P < 0.001, There was no significant effect of time or time x treatment interaction.
  3. 3n = 59.